Clinical Trial Update: Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for dendritic cell-based immunotherapy in gastric cancer is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Dendritic cell-based immunotherapy

Snippet

Sponsor: LanZhou University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN